Pinealon

This in vitro study examined the synthetic tripeptide Pinealon (Glu-Asp-Arg) across three cell models: rat cerebellar granule cells, neutrophils, and PC12 pheochromocytoma cells. The authors reported a dose-dependent restriction of reactive oxygen species (ROS) accumulation under oxidative stress induced by both receptor-dependent and receptor-independent stimuli, accompanied by a reduction in necrotic cell death as measured by the propidium iodide assay. The protective effect was associated with a delayed time course of ERK 1/2 activation and observed modification of the cell cycle. The authors noted that ROS restriction saturated at lower concentrations while cell-cycle modulation continued at higher concentrations, and proposed that, in addition to antioxidant activity, Pinealon may interact directly with the cell genome. Independent replication of these findings outside the Khavinson research lineage has been limited in the indexed Western literature.

Scientists looked at how Pinealon behaves in three different kinds of cells in laboratory dishes: brain cells from rat cerebellum, immune cells, and a standard nerve-cell line called PC12. They stressed the cells with chemicals that produce damaging molecules called free radicals, then measured what Pinealon changed. At low doses, Pinealon reduced the buildup of free radicals and the number of cells that died. At higher doses, it also appeared to affect the cell's internal "growth cycle" — the timing program that controls when cells divide. The researchers suggested this points to two separate effects: an antioxidant action and a direct interaction with the cell's genetic machinery. This is one of the foundational laboratory studies on Pinealon, though the work was conducted by the same research group that developed the peptide.

This animal study examined whether administration of Pinealon to pregnant rats loaded with methionine — a model of prenatal hyperhomocysteinemia — would alter neurodevelopmental outcomes in their offspring. Offspring of methionine-loaded dams that also received Pinealon were assessed on spatial orientation and learning tasks and were compared with offspring from untreated methionine-loaded dams and control dams. The authors reported that the Pinealon group showed improved spatial orientation and learning performance relative to the untreated hyperhomocysteinemia group. Cerebellar neurons isolated from Pinealon-group offspring also showed lower reactive oxygen species accumulation and a reduced fraction of necrotic cells in ex vivo assays. The authors interpret the findings as consistent with the antioxidant and neuroprotective profile reported in their earlier in vitro work. As with the 2011 paper above, this study originates from the Khavinson research lineage.

Researchers wanted to know whether giving Pinealon to pregnant rats could protect their pups from brain damage caused by elevated homocysteine — a stress state created by feeding the mother extra methionine. After birth, the pups were tested on simple maze and learning tasks, and their cerebellar brain cells were examined under a microscope. The pups whose mothers received Pinealon learned better than the pups from stressed mothers who did not get the peptide. Their brain cells also showed less oxidative damage and fewer dead cells. The authors suggested that Pinealon's antioxidant effects observed in laboratory dishes also appear in this rodent pregnancy model. Researchers should weigh this finding against the fact that the work comes from the same research group that originally described the peptide.